Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

63850 1504871583HCLSReviewHongKongSeptember2017.pdf
Energy Boardroom

Big Pharma aims to cast off old drugs to raise $42B for higher-profit R&D efforts

05.05.2014 / Fierce Pharma

Sanofi, Merck, and Abbott Laboratories are all planning to sell off portfolios of drugs that have lost their patent protection. The proceeds from such sales could be significant–$7 billion for Sanofi, $15 billion for Merck, and $5 billion for Abbott. Add in AstraZeneca, whose CEO proposed deals for its neuroscience and anti-infectives businesses, and you have another $15 billion in potential proceeds–a total of $42 billion.

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: